Answers are grounded in this paper and cite their sources.
Hepatitis C virus (HCV) infection is one of the commonest causes of liver cirrhosis and hepatocellular carcinoma. This review deals with treatment of chronic HCV infection with a combination of interferon and ribavirin. Recent trials have shown that approximately 40% of patients will clear HCV with combination treatment. This is an important advance in the treatment of this serious viral infection.
No takes yet. Share an insight, caveat, or question.
Christie et al. (1999) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: